PharmaCyte Biotech, Inc. (PMCB)

NASDAQ: PMCB · Real-Time Price · USD

0.8815

-0.0394 (-4.28%)

At close: Jan 9, 2026, 4:00 PM EST

0.9032

+0.0217 (2.46%)

After-hours: Jan 9, 2026, 7:35 PM EST

PharmaCyte Biotech Income Statement

Financials in millions USD. Fiscal year is May - April.

Millions USD. Fiscal year is May - Apr.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2016 - 2020
Period Ending	Oct '25 Oct 31, 2025	Apr '25 Apr 30, 2025	Apr '24 Apr 30, 2024	Apr '23 Apr 30, 2023	Apr '22 Apr 30, 2022	Apr '21 Apr 30, 2021	2016 - 2020
Selling, General & Admin	3.75	3.94	6.11	5.99	3.7	2.71	Upgrade
Research & Development	0.48	0.44	0.41	0.47	0.69	0.92	Upgrade
Operating Expenses	4.23	4.38	6.52	6.46	4.39	3.62	Upgrade
Operating Income	-4.23	-4.38	-6.52	-6.46	-4.39	-3.62	Upgrade
Interest Expense	-	-	-	-	-0	-0	Upgrade
Interest & Investment Income	0.91	1.42	3.4	1.94	0.16	-	Upgrade
Other Non Operating Income (Expenses)	-7.23	9.11	5.45	0.2	-0	-0	Upgrade
EBT Excluding Unusual Items	-10.55	6.15	2.33	-4.32	-4.24	-3.63	Upgrade
Gain (Loss) on Sale of Investments	5.38	26.53	-	-	-	-	Upgrade
Asset Writedown	-	-	-2	-	-	-	Upgrade
Legal Settlements	-1.91	-2.02	-	-	-	-	Upgrade
Other Unusual Items	-	-	-	-	-	0.08	Upgrade
Pretax Income	-7.07	30.66	0.33	-4.32	-4.24	-3.55	Upgrade
Net Income	-7.07	30.66	0.33	-4.32	-4.24	-3.55	Upgrade
Preferred Dividends & Other Adjustments	0.56	7.29	17.57	-	-	-	Upgrade
Net Income to Common	-7.63	23.36	-17.24	-4.32	-4.24	-3.55	Upgrade
Net Income Growth	-	9084.98%	-	-	-	-	Upgrade
Shares Outstanding (Basic)	7	7	10	19	16	1	Upgrade
Shares Outstanding (Diluted)	7	7	10	19	16	1	Upgrade
Shares Change (YoY)	-15.57%	-23.50%	-50.84%	25.56%	971.73%	60.24%	Upgrade
EPS (Basic)	-1.11	3.19	-1.80	-0.22	-0.27	-2.45	Upgrade
EPS (Diluted)	-1.11	3.19	-1.80	-0.22	-0.27	-2.45	Upgrade
EBIT	-4.23	-4.38	-6.52	-6.46	-4.39	-3.62	Upgrade

Updated Oct 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q